Sources:

[1]

Reference Icon
Aetna

[2]

Reference Icon
Bcbs

[3]

Reference Icon
Providerfinderonline
Overview
Practice
About
Publications

Dr. Timothy Anthony Yap, Mdverified

Is this you? Claim your identity
No phone calls, no waiting on hold

2.0
(62)

Specialty icon
Specialties
Oncology, Medical Oncology, General Oncology
Bio icon
Bio:
With over 20 years of expertise in oncology, this passionate healthcare provider is dedicated to delivering exceptional cancer care and empowering pat...
Experience icon
Experience:
20+ years
Sex icon
Sex:
Male
Languages Spoken icon
Languages Spoken:
English
Location icon
Location
Houston, TX
Common Treatments icon
Common Treatments:
Adrenal Gland Cancer
Anemia
Bladder Cancer
See More
Institutes Attended icon
Institutes Attended:
ICLSM
TMB
OSBMLS
Certificates icon
Certificates:
MD
TX License
OK License
NPI/License number icon
NPI/License number:
1942743216
Hospital Affiliations icon
Hospital Affiliations:
The University of Texas Md Anderson Cancer Center
See More
AZ Awards icon
AZ Awards:
226
Common Treatments icon
Common Treatments:
Adrenal Gland Cancer
Anemia
Bladder Cancer
See More
Institutes Attended icon
Institutes Attended:
ICLSM
TMB
OSBMLS
Certificates icon
Certificates:
MD
TX License
OK License
NPI/License number icon
NPI/License number:
1942743216
Hospital Affiliations icon
Hospital Affiliations:
The University of Texas Md Anderson Cancer Center
See More
AZ Awards icon
AZ Awards:
226
This is an AZ search result. This provider is not affiliated, endorsing or endorsed by AZcare.

Last updated on: 5/1/2025
specOverviewGenerated by AZ
Dr. Timothy Anthony Yap is a highly respected and experienced medical oncologist practicing in Houston, Texas. A graduate of the Imperial College London School of Medicine, Dr. Yap brings over 20 years of expertise to the field, specializing in the comprehensive treatment of a wide range of cancers. His areas of expertise include, but are not limited to, lung, breast, prostate, pancreatic, and gastrointestinal cancers, as well as anemias and soft tissue sarcomas. Dr....
specPractice
insurance
In-network insurance plans
Aetna
Blue Cross Blue Shield
Blue Cross Blue Shield of Texas
Blue Cross Blue Shield of Massachusetts
Blue Cross Blue Shield of Michigan
Cigna
Insurance info is for reference only. Contact the provider to confirm they accept your plan, as some may decline certain insurances even if technically in-network.
insurance
Appointments Scheduling
UT MD Anderson Cancer Center
Avatar iconIn-Person Visit
Warning unverified location iconUnverified location
location icon

Address:

1515 Holcombe Blvd, Houston, TX 77030
faxIcon

Fax:

(713) 563-6622

specAbout
Education IconReviews
We don't have reviews for this provider yet. Feel free to write a review and share your experience!
Specialties icon
Specialties:
Oncology
Medical Oncology
General Oncology
Common Treatments icon
Common Treatments:
Adrenal Gland Cancer
NPI/License number icon
NPI/License number:
1942743216
Experience icon
Experience:
20+ years
Languages Spoken icon
Languages Spoken:
English
Hospital Affiliations icon
Hospital Affiliations:
The University of Texas Md Anderson Cancer Ce...
Sarasota Memorial Hospital
Education IconEducation & Certifications:
Education Icon
Medical Degree
Imperial College London School of Medicine2002
Education Icon
Texas State Medical License
Texas Medical Board
Education Icon
Oklahoma State Medical License
Oklahoma State Board of Medical Licensure and Supervision
specPublicationsSummarized by AZ
Publication Icon
Discovery of ART0380, a Potent and Selective ATR Kinase Inhibitor Undergoing Phase 2 Clinical Studies for the Treatment of Advanced or Metastatic Solid Cancers.
By Christopher L Carroll + 29 more
04-12-2024
No summary available for this publication.
Publication Icon
Synthetic lethal strategies for the development of cancer therapeutics.
By Natalie Y L Ngoi + 5 more
03-12-2024
No summary available for this publication.
Publication Icon
Oncology Combination Drug Development Strategies for Project Optimus.
By Julie Bullock + 8 more
02-12-2024
No summary available for this publication.
Publication Icon
UBA1 inhibition sensitizes cancer cells to PARP inhibitors.
By Sharad Awasthi + 17 more
27-11-2024
No summary available for this publication.
By using this site, you agree to our Terms and Conditions.